$AMRN This is HUGE. This study, from Dr. Bhaat et al of Harvard Medical, Brigham &Women's Hospital etc indicates Vascepa a viable alternative to VERY expensive bypass surgery, stents Insurance companies will be all over this to get patients on Vascepa. Sorry Hakima, Dr Reddy, Teva This is beyond your pay grade for your skinny generic.
  • 19
19 Likes